Double Standards in Medical Research in Developing Countries

by Ruth Macklin

Overview

This book examines the ethical controversies that have surrounded the design and conduct of international medical research sponsored by industrialized countries or industry, and carried out in developing countries. Is it acceptable to lower the ethical standards adopted in the industrialized world when carrying out research in developing, or resource-poor, countries? Ruth Macklin concludes that double standards in medical research are ethically unacceptable.

Product Details

ISBN-13:	9780521541701
Publisher:	Cambridge University Press
Publication date:	05/27/2004
Series:	Cambridge Law, Medicine and Ethics , #2
Edition description:	New Edition
Pages:	290
Product dimensions:	5.98(w) x 9.02(h) x 0.67(d)

About the Author

Professor of Bioethics, Albert Einstein College of Medicine, New York.

Table of Contents

1. International research contested: controversies and debates; 2. Maintaining ethical standards in research; 3. Striving for justice in research; 4. Avoiding exploitation; 5. providing safeguards: informed consent and review of research; 6. Making drugs affordable; 7. Respecting, protecting, and fulfilling human rights; 8. Striving for a single standard; Index.

Editorial Reviews

"The strength of the book lies in its breadth of coverage. It moves from deliberations over the wording of guidelines to theoretical considerations of the substantive content of those words, showing why their careful usage is ethically, and practically salient. Macklin's experience on international committees and study teams adds to the depth of her considerations. [S]he has made an important and timely contribution to the thinking of medical and pharmaceutical professionals, policymakers, and ethicists." Jackie Leach Scully, University of Basel, JAMA

"The strength of the book lies in its breadth of coverage. It moves from deliberations over the wording of guidelines to theoretical considerations of the substantive content of those words, showing why their careful usage is ethically, and practically salient. Macklin's experience on international committees and study teams adds to the depth of her considerations. [S]he has made an important and timely contribution to the thinking of medical and pharmaceutical professionals, policymakers, and ethicists." Jackie Leach Scully, University of Basel, JAMA

"[Macklin] has made an important and timely contribution to the thinking of medical and pharmaceutical professionals, poicymakers, and ethicists." JANA

From the Publisher